PG

Phil Grayeski

Partner @ KdT Ventures

Raleigh-Durham-Chapel Hill Area

Invests in

Stages:

  • Min Investment:

    $700,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $850,000.00

Education

Work Experience

  • Partner

    2021

    Board Observer: - Radar Therapeutics - Tacit Therapeutics - Circularis (acq. by Gingko Q4 2022) - Transcera

  • Principal

    2019 - 2021

  • Venture Associate

    2018 - 2019

  • Board Member

    2023

  • Board Member

    2022

2020

  • Board Member

    2020

  • Co-Founder

    2018

2021 - 2023

  • Board Member

    2021 - 2023

2021 - 2023

  • Board Member

    2021 - 2023

2015 - 2019

  • Strategy Advisor and Business Analyst

    2015 - 2019

    Acq. by Gingko Bioworks - May 2023

2016 - 2017

  • Strategy Advisor and Business Analyst

    2016 - 2017